Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes

BACKGROUND: The therapeutic potential of mesenchymal stem cells (MSCs) in type 1 diabetes (T1D) has been demonstrated in both preclinical and clinical studies. MSCs that have been used in research on T1D are derived from various tissue sources, with bone marrow (BM) and umbilical cord (UC) tissues b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Ling, Qing, Wang, Bin, Wang, Kai, Pang, Jianbo, Lu, Jing, Bi, Yan, Zhu, Dalong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358877/
https://www.ncbi.nlm.nih.gov/pubmed/35941696
http://dx.doi.org/10.1186/s13287-022-02974-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358877/
https://www.ncbi.nlm.nih.gov/pubmed/35941696
http://dx.doi.org/10.1186/s13287-022-02974-1

Ejemplares similares